| 摘要 |
<p>Antigenic peptides are provided that can be used to induce global neutralizing antibodies, or antibodies reactive against a wide range of influenza A virus strains. The antigenic peptide can correspond to SEQ ID NO: 34 (EKEVLVLWG), SEQ ID NO: 2 (KFDKLYIWG), SEQ ID NO: 71(QEDLLVLWG), SEQ ID NO: 51 (EGRINYYWTLLEP), SEQ ID NO: 3 (PSRISIYWTIVKP), and/or SEQ ID NO: 82 (SGRMEFFWTILKP).</p> |
| 申请人 |
OSAKA UNIVERSITY;THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OFOSAKA UNIVERSITY;BENESIS CORPORATION;MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD;MITSUBISHI TANABE PHARMA CORPORATION;IKUTA, KAZUYOSHI;KOKETSU, RITSUKO;YAMASHITA, AKIFUMI;KAWASHITA, NORIHITO;YUNOKI, MIKIHIRO;OKUNO, YOSHINOBU;IDENO, SHOJI;KUHARA, MOTOKI |
发明人 |
IKUTA, KAZUYOSHI;KOKETSU, RITSUKO;YAMASHITA, AKIFUMI;KAWASHITA, NORIHITO;YUNOKI, MIKIHIRO;OKUNO, YOSHINOBU;IDENO, SHOJI;KUHARA, MOTOKI |
